UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Clinical trials for UNDIFFERENTIATED PLEOMORPHIC SARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNDIFFERENTIATED PLEOMORPHIC SARCOMA trials appear
Sign up with your email to follow new studies for UNDIFFERENTIATED PLEOMORPHIC SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted drug tested for tough-to-treat cancers
Disease control CompletedThis study tested a new drug called mecbotamab vedotin, both by itself and combined with an existing immunotherapy drug (nivolumab), in people with advanced solid tumors, specifically certain types of sarcoma. The main goals were to find safe doses and see if the treatment could …
Matched conditions: UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: BioAtla, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists hunt for clues to match sarcoma patients with treatment
Knowledge-focused CompletedThis study aimed to find biological markers that could predict which patients with advanced soft-tissue sarcoma would respond well to the drug trabectedin. Researchers collected tumor and blood samples from 29 adult patients before, during, and after treatment to analyze their ge…
Matched conditions: UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC